XML 49 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation
6 Months Ended 12 Months Ended
Jan. 31, 2023
Jul. 31, 2022
Stock-Based Compensation [Abstract]    
STOCK-BASED COMPENSATION

NOTE 4 - STOCK-BASED COMPENSATION

 

In November 2015, the Company adopted the Digerati Technologies, Inc. 2015 Equity Compensation Plan (the “Plan”). The Plan authorizes the grant of up to 7.5 million stock options, restricted common shares, non-restricted common shares and other awards to employees, directors, and certain other persons. The Plan is intended to permit the Company to retain and attract qualified individuals who will contribute to the overall success of the Company. The Company’s Board of Directors determines the terms of any grants under the Plan. Exercise prices of all stock options and other awards vary based on the market price of the shares of common stock as of the date of grant. The stock options, restricted common stock, non-restricted common stock, and other awards vest based on the terms of the individual grant.

 

During the six months ended January 31, 2023 and 2022, the Company did not issue any new stock options.

 

The Company recognized approximately $45,793 and $46,788, respectively, in stock-based compensation expense for stock options to employees for the six months ended January 31, 2023 and 2022. Unamortized compensation stock option cost totaled $52,179 and $149,047, respectively, as of January 31, 2023 and 2022.

 

A summary of the stock options outstanding as of January 31, 2023 and July 31, 2022, and the changes during the six months ended January 31, 2023 are presented below:

 

       Weighted
average
exercise
   Weighted
average
remaining
contractual
 
   Options   price   term (years) 
Outstanding at July 31, 2022   9,130,000   $0.17    2.39 
Granted   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Forfeited and cancelled   (1,355,000)   0.35    
-
 
Outstanding on January 31, 2023   7,775,000   $0.12    2.24 
Exercisable on January 31, 2023   6,756,246   $0.13    2.15 

 

The aggregate intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) of the 7,775,000 and 9,130,000 stock options outstanding as of January 31, 2023 and July 31, 2022, was $172,326 and $191,722, respectively.

 

The aggregate intrinsic value of 6,764,444 and 7,551,179 stock options exercisable on January 31, 2023 and July 31, 2022 was $125,970 and $110,380, respectively.

 
DIGERATI TECHNOLOGIES, INC [Member]    
Stock-Based Compensation [Abstract]    
STOCK-BASED COMPENSATION  

NOTE 6 - STOCK-BASED COMPENSATION

 

In November 2015, the Company adopted the Digerati Technologies, Inc. 2015 Equity Compensation Plan (the “Plan”). The Plan authorizes the grant of up to 7.5 million stock options, restricted common shares, non-restricted common shares and other awards to employees, directors, and certain other persons. The Plan is intended to permit the Company to retain and attract qualified individuals who will contribute to the overall success of the Company. The Company’s Board of Directors determines the terms of any grants under the Plan. Exercise prices of all stock options and other awards vary based on the market price of the shares of common stock as of the date of grant. The stock options, restricted common stock, non-restricted common stock, and other awards vest based on the terms of the individual grant.

 

During the year ended July 31, 2022, the Company extended the expiration date on 1,150,000 previously issued stock options to various employees until July 31, 2025, and the exercise price of these options was set at $0.11 per share. The modification of these stock options created a nominal expense to the Company.

 

During the year ended July 31, 2021, we issued:

 

  7,858,820 shares of common stock to various employees for services in lieu of cash compensation and as part of the Company’s Non-Standardized profit-sharing plan. The Company recognized stock-based compensation expense of $264,712 equivalent to the value of the shares calculated based on the share’s closing price at the grant dates.

 

  4,230,000 options to purchase common shares to various employees with an exercise price ranging from $0.042 to $0.1475 per share and a term of 5 years. At issuance, 200,000 of the options vested, 400,000 of the options will vest equally over a period of two years, and 3,630,000 of the options will vest equally over a period of three years. At issuance the stock options had a fair market value of $267,343.

 

The fair market value of all options issued during the year ended July 31, 2021, were determined using the Black-Scholes option pricing model which used the following assumptions:

 

Expected dividend yield     0.00%
Expected stock price volatility     197.71% - 198.82%
Risk-free interest rate     0.22% - 0.34%
Expected term     2.0 - 3.0 years.  

Digerati recognized approximately $98,000 and $399,500 in stock-based compensation expense to employees during the years ended July 31, 2022, and 2021, respectively. Unamortized compensation cost totaled $97,972 and $195,835 at July 31, 2022, and July 31, 2021, respectively.

 

A summary of the stock options as of July 31, 2022, and July 31, 2021, and the changes during the years ended July 31, 2022, and July 31, 2021:

 

   Options   Weighted-
average
exercise
price
   Weighted-
average
remaining
contractual
term
(years)
 
             
Outstanding at July 31, 2020   5,000,000   $0.27    2.66 
Granted   4,230,000   $0.05    4.39 
Exercised   
-
    
-
    
-
 
Forfeited and cancelled   
-
    
-
    
-
 
Outstanding at July 31, 2021   9,230,000   $0.17    2.93 
Granted   
-
    
-
    
-
 
Exercised   
-
    
-
    
-
 
Forfeited and cancelled   (100,000)  $0.25    
-
 
Outstanding at July 31, 2022   9,130,000   $0.17    2.39 
Exercisable at July 31, 2022   7,551,179   $0.20    2.11 

 

The aggregate intrinsic value (the difference between the Company’s closing stock price on the last trading day of the period and the exercise price, multiplied by the number of in-the-money options) of the 9,130,000 and 9,230,000 stock options outstanding at July 31, 2022 and July 31, 2021 was $191,722 and $392,891, respectively.

 

The aggregate intrinsic value of the 7,551,179 and 6,091,863 stock options exercisable at July 31, 2022 and July 31, 2021 was $110,380 and $91,978, respectively.